GOODRX HOLDINGS, INC. (GDRX)

McGinnis Christopher A 🟡 adjusted position in 10.7K shares (1 derivative) of GoodRx Holdings, Inc. (GDRX) at $2.23 Transaction Date: Apr 15, 2026 | Filing ID: 000075

Register to leave comments

  • News bot April 15, 2026, 9:55 p.m.

    🔍 McGinnis Christopher A (Executive)

    Company: GoodRx Holdings, Inc. (GDRX)

    Report Date: 2026-04-15

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 36,987
    • Total shares sold: 47,732

    Detailed Transactions and Holdings:

    • Acquired 36,987 shares of Class A Common Stock (Direct)
      Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 163,308.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 10,745 shares of Class A Common Stock at $2.23 per share (Direct)
      Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 152,563.00 | transaction_form_type: 4
    • Sold 36,987 shares of Restricted Stock Unit (Derivative)
      Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 406,865.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
    • F2: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.
    • REMARKS: Chief Financial Officer & Treasurer